• Ionomycin Calcium Salt: Precision Calcium Ionophore for Canc

  2026-05-09

  Ionomycin calcium salt is a benchmark calcium ionophore, driving reproducible elevation of intracellular Ca2+ for cancer research and advanced cell signaling assays. Learn how this APExBIO solution empowers high-impact protocols, detailed troubleshooting, and robust experimental design.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-05-08

  This study introduces a novel assembloid model for gastric cancer, integrating patient-matched tumor organoids and diverse stromal cell subpopulations. The model enables in-depth analysis of tumor–stroma interactions and reveals how stromal diversity modulates gene expression and drug sensitivity, offering a more physiologically relevant platform for preclinical research.

• Dual “Engage & Evasion” Strategy Enhances EV Therapy Efficac

  2026-05-07

  Liu et al. introduce a two-step ‘Engage & Evasion’ administration approach to overcome rapid mononuclear phagocyte system (MPS) clearance of extracellular vesicles (EVs), improving their systemic distribution for ischemic disease therapy. By sequentially saturating the MPS and delivering CD47-enriched EVs, the study demonstrates significantly increased EV retention and organ targeting.

• Losartan Nanohydrogel Remodels Tumor Mechanics to Overcome T

  2026-05-07

  Hou et al. (2024) demonstrate that a Losartan-based nanocomposite hydrogel can remodel the tumor mechanical microenvironment, reversing resistance to chemo-immunotherapy. By targeting extracellular matrix stiffness, the study provides a new mechanistic rationale for combining angiotensin II receptor antagonists with standard cancer treatments to enhance therapeutic sensitivity.

• SD 169 (indole-5-carboxamide): Precision MAPK Inhibitor Work

  2026-05-06

  SD 169 (indole-5-carboxamide) offers dual-action inhibition for p38 MAPK pathway research, supporting advanced applications in type 1 diabetes and axonal regeneration. This guide provides evidence-based workflows, troubleshooting tips, and protocol parameters to maximize reproducibility and translational impact.

• Diuron (C6731): Mechanistic Toxicology and Research Protocol

  2026-05-06

  Explore the molecular toxicology of Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) with a focus on network-based mechanisms and nephrotoxicity. This article delivers advanced insights for researchers seeking to optimize herbicide assays and understand Diuron's environmental and biological impacts.

• Bovine Insulin: Metabolic Signaling and Translational Levera

  2026-05-05

  Explore how bovine insulin, beyond its classical growth supplement role, enables advanced modeling of insulin signaling and mitochondrial quality control. Grounded in recent mechanistic research, this article provides strategic guidance for translational researchers seeking to bridge metabolic regulation with neuronal health and disease modeling, highlighting protocol nuances, competitive insights, and future-impact considerations.

• Fangchinoline Restores Lysosomal Biogenesis to Block H1N1 In

  2026-05-05

  This study demonstrates that fangchinoline activates TFEB-driven lysosomal biogenesis, counteracting H1N1 influenza virus strategies that disrupt lysosomal function. The findings identify a novel lysosome-centered antiviral mechanism, expanding potential therapeutic strategies against viral immune evasion.

• Amitriptyline HCl: Technical Guide for Neuropharmacology Res

  2026-05-04

  Amitriptyline HCl is a validated tricyclic compound used for targeted neurotransmitter receptor modulation in neuropharmacology and mood disorder research. This product provides reliable solubility and receptor inhibition benchmarks for experimental designs but should not be used for applications outside validated CNS research models. Its workflow is optimized for precision, solubility, and purity under controlled conditions.

• Reliable mRNA Delivery with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-05-04

  This article addresses persistent challenges in cell-based assays—such as inconsistent transfection and unreliable viability readouts—by spotlighting the advanced features of EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011). We explore evidence-backed scenarios where its dual-fluorescent labeling, Cap 1 structure, and immune-silent chemistry drive reproducible, high-sensitivity gene delivery and functional protein expression. Researchers gain practical, data-driven answers for optimizing workflow efficiency and data reliability.

• PTH (1-34) (Human): Mechanistic Leverage for Translational R

  2026-05-03

  Explore how Parathyroid hormone (1-34) (human) enables mechanistic dissection of bone and cardiovascular calcification, with actionable guidance for translational models and critical insights from recent CKD-related valvular calcification studies.

• I-BET151 (GSK1210151A): Selective BET Inhibitor Evidence Rev

  2026-05-02

  I-BET151 (GSK1210151A) is a potent, selective BET bromodomain inhibitor for cancer research. It targets BRD2, BRD3, and BRD4, disrupting transcriptional programs central to tumorigenesis and inflammation. This review details its mechanism, benchmarks in apoptosis and cell cycle arrest assays, and integration into modern cancer biology workflows.

• DMH-1 as a Precision ALK2 Inhibitor: Unlocking Controlled Ce

  2026-05-02

  Explore how DMH-1, a potent ALK2 inhibitor, enables unprecedented control over cell differentiation and proliferation in organoid and non-small cell lung cancer research. This article delivers actionable guidance and deep analysis for optimizing experimental outcomes.

• Protease and Phosphatase Inhibitor Cocktail in Protein Extra

  2026-05-01

  Unlock reproducible protein extraction and phosphorylation preservation with the EDTA-free Protease and Phosphatase Inhibitor Cocktail. Discover workflow advances and troubleshooting strategies for sensitive cell signaling and cardiac differentiation assays.

• G007-LK Tankyrase 1/2 Inhibitor: Precision Tools for Wnt Pat

  2026-04-30

  G007-LK offers researchers a robust, selective means to inhibit tankyrase 1/2 and dissect Wnt/β-catenin and Hippo signaling in APC-mutant colorectal cancer and liver cancer models. This article details experimental workflows, protocol refinements, and practical troubleshooting for maximizing data quality with G007-LK, leveraging insights from both peer-reviewed and workflow-driven sources.

454 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page